Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

2.06USD
4:44pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.06
Open
$2.06
Day's High
$2.10
Day's Low
$2.06
Volume
5,461
Avg. Vol
36,299
52-wk High
$2.90
52-wk Low
$0.60

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)
No analyst recommendations are available for .

Overall

Beta: 2.47
Market Cap(Mil.): $72.60
Shares Outstanding(Mil.): 33.15
Dividend: --
Yield (%): --

Financials

  CRIS.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.96 -- --
ROI: -64.85 7.52 12.69
ROE: -8,594.04 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates